ResearcherUniversity of CyprusNo recent work listed

Andreas Stylianou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1641-1854; OpenAlex author ID A5065216516. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Pancreatic Cancer Presents Distinct Nanomechanical Properties During Progression. Co-author DOI 10.1007/s10439-023-03168-3 ↗
Transforming growth factor-β modulates pancreatic cancer associated fibroblasts cell shape, stiffness and invasion. Co-author DOI 10.1016/j.bbagen.2018.02.009 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Triantafyllos Stylianopoulos · 2 shared papers, 2018–2023 · strength 0.40
- Paper Pancreatic Cancer Presents Distinct Nanomechanical Properties During Progression. DOI 10.1007/s10439-023-03168-3 ↗
- Paper Transforming growth factor-β modulates pancreatic cancer associated fibroblasts cell shape, stiffness and invasion. DOI 10.1016/j.bbagen.2018.02.009 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.